Kurs
+6,17%
Likviditet
0,07 MSEK
Kalender
Tid* | ||
2025-05-12 | N/A | X-dag ordinarie utdelning ATANA 0.00 SEK |
2025-05-09 | N/A | Årsstämma |
2025-05-09 | 21:30 | Kvartalsrapport 2025-Q1 |
2025-02-21 | 21:30 | Bokslutskommuniké 2024 |
2024-11-01 | - | Kvartalsrapport 2024-Q3 |
2024-10-31 | - | Extra Bolagsstämma 2025 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-05-03 | - | Årsstämma |
2024-05-03 | - | Kvartalsrapport 2024-Q1 |
2024-02-23 | - | Bokslutskommuniké 2023 |
2023-10-27 | - | Kvartalsrapport 2023-Q3 |
2023-08-18 | - | Kvartalsrapport 2023-Q2 |
2023-05-08 | - | X-dag ordinarie utdelning ATANA 0.00 SEK |
2023-05-05 | - | Årsstämma |
2023-05-05 | - | Kvartalsrapport 2023-Q1 |
2023-02-24 | - | Bokslutskommuniké 2022 |
2022-12-07 | - | Extra Bolagsstämma 2022 |
2022-11-25 | - | Kvartalsrapport 2022-Q3 |
2022-08-19 | - | Kvartalsrapport 2022-Q2 |
2022-05-09 | - | X-dag ordinarie utdelning ATANA 0.00 SEK |
2022-05-06 | - | Årsstämma |
2022-05-06 | - | Kvartalsrapport 2022-Q1 |
2022-02-25 | - | Bokslutskommuniké 2021 |
2021-11-26 | - | Kvartalsrapport 2021-Q3 |
2021-08-17 | - | Kvartalsrapport 2021-Q2 |
2021-05-10 | - | X-dag ordinarie utdelning ATANA 0.00 SEK |
2021-05-07 | - | Årsstämma |
2021-05-07 | - | Kvartalsrapport 2021-Q1 |
2021-02-25 | - | Bokslutskommuniké 2020 |
2020-11-27 | - | Kvartalsrapport 2020-Q3 |
2020-11-09 | - | Extra Bolagsstämma 2020 |
2020-08-27 | - | Kvartalsrapport 2020-Q2 |
2020-05-11 | - | X-dag ordinarie utdelning ATANA 0.00 SEK |
2020-05-08 | - | Årsstämma |
2020-05-08 | - | Kvartalsrapport 2020-Q1 |
2020-02-24 | - | Bokslutskommuniké 2019 |
2019-11-29 | - | Kvartalsrapport 2019-Q3 |
2019-08-09 | - | Extra Bolagsstämma 2019 |
2019-08-07 | - | Kvartalsrapport 2019-Q2 |
2019-05-08 | - | X-dag ordinarie utdelning ATANA 0.00 SEK |
2019-05-07 | - | Kvartalsrapport 2019-Q1 |
2019-04-05 | - | Årsstämma |
2019-02-26 | - | Bokslutskommuniké 2018 |
2018-05-08 | - | X-dag ordinarie utdelning ATANA 0.00 SEK |
2018-05-07 | - | Årsstämma |
2018-02-22 | - | Bokslutskommuniké 2017 |
Beskrivning
Land | Sverige |
---|---|
Lista | Nordic SME Sweden |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
In the paper in "Journal of Colloid And Interface Science (https://www.sciencedirect.com/science/article/pii/S0021979723015990)", the Attana quartz crystal microbalance (QCM) is applied to study the electrical response of two ionic liquids. Controlled by an applied electric field, the structure and interaction of ionic liquids on the surface, can be monitored and optimized. This is of high importance for the development of e.g. environment friendly lubricants. This is the third paper by the team of Prof Ruthland that demonstrates how Attana technology can be applied to monitor interaction properties by changing the electrical potential at surfaces.
For drug development this is of importance because many interactions in the human body are strongly affected by electrical charges at e.g. the cell surfaces. The pH of human liquids is different, e.g in the blood stream or inside a cell, and that effects the surface charges. Therefore, there is a potential for drug development to tailor local charges on drug molecules such as antibodies, which can then be applied to minimize off-target interactions or improve target interactions. Thanks to Prof. Ruthland's work Attana technology can be applied to optimize drug properties with respect to electrostatic interactions.
[En bild som visar illustration, design
Automatiskt genererad beskrivning med låg exakthet][En bild som visar text, skärmbild, linje, diagram
Automatiskt genererad beskrivning]
Marcus Söderberg
CEO Attana AB
ir@attana.com
+46 708 86 23 00
The Board of directors for Attana consider that the information in this press release is not likely to have a significant effect on the share price but is of general interest for the shareholders and hence should be communicated.